Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 671.00
+31.65 (4.95%)
Sep 4, 2026, 3:29 PM IST
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 71.07 billion as of September 4, 2026. Its market cap has increased by 324.60% in one year.
Market Cap
71.07B
Enterprise Value
69.79B
Revenue
10.05B
Ranking
n/a
PE Ratio
52.18
Stock Price
671.00
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 71.07B, an increase of 706,890.37%. That is a compound annual growth rate of 43.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 71.07B | 310.87% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NATCO Pharma | 150.15B |
| Sudeep Pharma | 146.02B |
| Akums Drugs and Pharmaceuticals | 119.50B |
| Strides Pharma Science | 97.11B |
| Aarti Pharmalabs | 78.70B |
| Sun Pharma Advanced Research Company | 65.73B |
| Innova Captab | 64.40B |
| Orchid Pharma | 47.40B |